(7-Methoxy-2,2-diphenyl-benzo[1,3]dioxol-5-yl)-carbamic acid 2-trimethylsilanyl-ethyl ester | 717131-60-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (7-Methoxy-2,2-diphenyl-benzo[1,3]dioxol-5-yl)-carbamic acid 2-trimethylsilanyl-ethyl ester
• CAS: 717131-60-7
• 化学式: C₂₆H₂₉NO₅Si
• 分子量: 463.605
• InChiKey: NLWJEHGLWMUYHY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.25
• 重原子数：
  33.0
• 可旋转键数：
  7.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  66.02
• 氢给体数：
  1.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  (7-Methoxy-2,2-diphenyl-benzo[1,3]dioxol-5-yl)-carbamic acid 2-trimethylsilanyl-ethyl ester 在 吡啶 、 四丁基氟化铵 、 木榴油 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 、 乙腈 为溶剂， 生成 2-(3,4-dihydroxy-5-methoxy-phenylcarbamoyl)-8-hydroxyquinoline-7-carboxylic acid
  参考文献：
  名称：

  Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activity

  摘要：

  A novel series of HIV-1 integrase inhibitors was synthesized and tested in both in vitro and ex vivo assays. These inhibitors are featured by the presence of a quinoline subunit and an ancillary aromatic ring linked by functionalized spacers such as amide, hydrazide, urea and 1-hydroxyprop-l-en-3-one moiety. Amide derivatives are the most promising ones and could serve as leads for further developments. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.03.005
• 作为产物：
  描述：

  7-甲氧基-2,2-二苯基-1,3-苯并二氧代-5-羧酸甲酯 在 sodium hydroxide 、 叠氮磷酸二苯酯 作用下， 以 甲醇 为溶剂， 生成 (7-Methoxy-2,2-diphenyl-benzo[1,3]dioxol-5-yl)-carbamic acid 2-trimethylsilanyl-ethyl ester
  参考文献：
  名称：

  Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activity

  摘要：

  A novel series of HIV-1 integrase inhibitors was synthesized and tested in both in vitro and ex vivo assays. These inhibitors are featured by the presence of a quinoline subunit and an ancillary aromatic ring linked by functionalized spacers such as amide, hydrazide, urea and 1-hydroxyprop-l-en-3-one moiety. Amide derivatives are the most promising ones and could serve as leads for further developments. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.03.005